BIOLASE, Inc.
BIOLQ
$0.0078
$0.00034.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 48.96% | 56.85% | -21.76% | -16.06% | 5.73% |
| Total Depreciation and Amortization | -0.77% | -1.52% | -0.75% | 18.75% | -60.67% |
| Total Amortization of Deferred Charges | 0.00% | -87.75% | 800.94% | -67.78% | -0.60% |
| Total Other Non-Cash Items | 3.59% | -306.38% | -42.07% | 214.23% | 310.77% |
| Change in Net Operating Assets | -223.43% | 248.01% | -208.44% | 69.59% | 264.40% |
| Cash from Operations | -509.26% | 87.64% | -160.10% | 11.79% | 27.34% |
| Capital Expenditure | -48.15% | -- | -- | -1.65% | 49.02% |
| Sale of Property, Plant, and Equipment | -14.94% | -55.84% | 8.24% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -43.33% | -69.54% | 6,666.67% | 98.35% | 49.02% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | -324.24% | 0.00% | -- | -- |
| Issuance of Common Stock | -- | -99.93% | 165.90% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -100.00% | -- | -- | -100.00% | -10.04% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.00% | -- | -100.00% | -10.13% |
| Cash from Financing | 681.78% | -107.58% | 538.08% | -76.44% | -12.16% |
| Foreign Exchange rate Adjustments | 731.58% | 75.95% | -150.00% | 247.66% | -360.98% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -63.07% | -547.98% | 86.08% | -241.41% | 120.85% |
